Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) saw an uptick in trading volume on Thursday . 6,826,500 shares changed hands during trading, an increase of 1,274% from the previous session’s volume of 496,659 shares.The stock last traded at $1.75 and had previously closed at $1.37.

Separately, ValuEngine raised shares of Ampio Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research report on Wednesday, October 11th.

COPYRIGHT VIOLATION WARNING: This news story was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The correct version of this news story can be read at https://www.watchlistnews.com/ampio-pharmaceuticals-inc-ampe-sees-unusually-high-trading-volume/1724988.html.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company’s two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for diabetic macular edema.

Receive News & Ratings for Ampio Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.